WATCH TIME: 6 minutes “It’s really key to understand all of the mechanisms that are involved and how the cells are interacting with each other, so...
Nicola De Stefano, MD, PhD New post-hoc data from the phase 4 MAGNIFY-MS trial (NCT03364036) showed that treatment with cladribine (Mavenclad; EMD Serono) resulted in increased...